Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0289656 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Yuqian Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP1A2, Catharanthus. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Hebei Administration Traditional Chinese Medicine.
Abstract (Originalsprache)
The objection of this study was to investigate the effects of vindoline(VDL) on the cytochrome P450 (CYP 450) isoforms (CYP1A2, 2B, 2C11, 2D1 and 3A) in rats. Firstly, the rats were randomly divided into VDL pretreatment group and blank group, each group had six rats. VDL pretreatment group was administrated VDL (20 mg·kg -1 ) by oral gavage for fifteen days consecutively, and the equivalent CMC-Na solution without VDL was given to the blank group by gavage. Secondly, a cocktail of caffeine, bupropion, diclofenac, dextromethorphan and midazolam was then administered on the sixteenth day. Finally, blood samples were collected at the specified time point, and the plasma concentration of the probe drug was determined by UHPLC-QTOF-MS/MS. The effects of VDL on the activity of these CYP enzymes in rats were evaluated by pharmacokinetic parameters. VDL pretreatment group compared with the blank group, accelerated the metabolism of diclofenac, and weakened the metabolism of caffeine. These results suggested that VDL could induce the activity of CYP2C11, and inhibits the activity of CYP1A2, but had no significant effects on CYP2B, CYP2D1 and CYP3A. The results in this study can provide beneficial information for the later clinical application of VDL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
- The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
ORCID-Profile: Yuqian Zhang
Förderung
- Scientific Research Project of Hebei Administration Traditional Chinese Medicine
Zitieren
APA
Zhang, Y., Niu, H., Liu, J., Xie, W., Jin, Y., & Zhang, Z. (2023). Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs. PLOS ONE. https://doi.org/10.1371/journal.pone.0289656
Vancouver
Zhang Y, Niu H, Liu J, Xie W, Jin Y, Zhang Z. Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs. PLOS ONE. 2023. doi:10.1371/journal.pone.0289656
BibTeX
@article{Zhang2023,
author = {Zhang, Yuqian and Niu, Haiying and Liu, Jian and Xie, Weiwei and Jin, Yiran and Zhang, Zhiqing},
title = {Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0289656}
}
EUVIMED